HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marion Ganslmayer Selected Research

Aminopyrine (Aminophenazone)

5/2005Hepatocellular carcinomas do not compromise quantitative tests of liver function.
4/2003Inducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve.
12/2002Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marion Ganslmayer Research Topics

Disease

9Hepatocellular Carcinoma (Hepatoma)
09/2015 - 02/2002
6Neoplasms (Cancer)
01/2014 - 11/2003
3Fibrosis (Cirrhosis)
05/2005 - 04/2002
2COVID-19
06/2022 - 01/2021
2Carcinoma (Carcinomatosis)
12/2007 - 11/2003
2Colorectal Neoplasms (Colorectal Cancer)
12/2007 - 11/2003
2Hepatitis C
09/2005 - 04/2003
1Post-Acute COVID-19 Syndrome
06/2022
1Sclerosing Cholangitis
04/2022
1Infections
01/2021
1Body Weight (Weight, Body)
01/2009
1Colonic Neoplasms (Colon Cancer)
12/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2007
1Adenocarcinoma
09/2007
1Chronic Hepatitis C
09/2005
1Liver Failure
02/2005
1Thrombocytopenia (Thrombopenia)
02/2005
1Thrombosis (Thrombus)
02/2005
1Neoplasm Metastasis (Metastasis)
06/2004
1Liver Cirrhosis (Hepatic Cirrhosis)
04/2003
1Inflammation (Inflammations)
12/2002
1Cholestasis
04/2002
1Ascites
04/2002

Drug/Important Bio-Agent (IBA)

5Histone Deacetylase InhibitorsIBA
12/2012 - 02/2002
3Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2011 - 05/2004
3theasinensin AIBA
09/2007 - 02/2002
3Aminopyrine (Aminophenazone)IBA
05/2005 - 12/2002
2Retinaldehyde (Retinal)IBA
06/2022 - 01/2021
2entinostat (MS 275)IBA
12/2012 - 08/2011
2Ribavirin (Virazole)FDA LinkGeneric
01/2009 - 09/2005
2trichostatin A (A 300)IBA
09/2007 - 02/2002
2Sorbitol (Yal)FDA Link
05/2005 - 12/2002
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2005 - 12/2002
2Galactose (Galactopyranose)FDA LinkGeneric
05/2005 - 12/2002
2EnzymesIBA
02/2005 - 12/2002
2TamoxifenFDA LinkGeneric
06/2004 - 05/2004
2Adapalene (Differin)FDA LinkGeneric
05/2004 - 11/2003
2RetinoidsIBA
05/2004 - 11/2003
2Caspase 3 (Caspase-3)IBA
05/2004 - 11/2003
1AutoantibodiesIBA
06/2022
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2022
1AngiotensinsIBA
01/2021
1PanobinostatIBA
09/2015
1Histone Deacetylases (Histone Deacetylase)IBA
08/2011
1peginterferon alfa-2a (Pegasys)FDA Link
01/2009
1A-423378.0IBA
12/2007
1GemcitabineFDA Link
09/2007
1InterferonsIBA
09/2005
1Antiviral Agents (Antivirals)IBA
09/2005
1VorinostatFDA Link
06/2005
1Fluorouracil (Carac)FDA LinkGeneric
06/2005
1Irinotecan (Camptosar)FDA LinkGeneric
06/2005
1Cardiolipins (Cardiolipin)IBA
02/2005
1AntibodiesIBA
02/2005
13,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
06/2004
1Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2004
1O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
05/2004
1AlitretinoinFDA Link
11/2003
1Bromodeoxyuridine (BrdU)IBA
11/2003
1procollagen Type III-N-terminal peptide (PIIP)IBA
04/2002

Therapy/Procedure

6Therapeutics
04/2022 - 05/2004
2Drug Therapy (Chemotherapy)
11/2003 - 02/2002